Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Core Laboratories N.V. (CLB)

Core Laboratories N.V. (CLB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 458,218
  • Shares Outstanding, K 44,444
  • Annual Sales, $ 668,210 K
  • Annual Income, $ 101,980 K
  • 60-Month Beta 2.35
  • Price/Sales 0.66
  • Price/Cash Flow 4.29
  • Price/Book 2.41

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/20
See More
  • Average Estimate 0.37
  • Number of Estimates 6
  • High Estimate 0.39
  • Low Estimate 0.35
  • Prior Year 0.44
  • Growth Rate Est. (year over year) -15.91%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.68 +57.78%
on 03/18/20
16.78 -37.19%
on 03/09/20
-13.30 (-55.79%)
since 03/06/20
3-Month
6.68 +57.78%
on 03/18/20
41.17 -74.40%
on 01/08/20
-30.70 (-74.44%)
since 01/07/20
52-Week
6.68 +57.78%
on 03/18/20
75.63 -86.06%
on 04/23/19
-60.20 (-85.10%)
since 04/05/19

Most Recent Stories

More News
Core Lab Reschedules Time And Location Of Its 2020 Annual Shareholder Meeting While Maintaining Meeting Date Of May 20, 2020

Core Laboratories N.V. (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA"), (the "Company" or "Core Lab") announces that on March 20, 2020, it filed its definitive proxy on form DEF-14A with the U.S. Securities...

CLB : 10.51 (+1.94%)
Core Laboratories' First Quarter 2020 Webcast At 7:30 A.M. CDT / 2:30 P.M. CEST On April 23, 2020

Core Laboratories (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") will broadcast its first quarter 2020 conference call over the Internet at 7:30 a.m. CDT / 2:30 p.m. CEST on April 23, 2020.

CLB : 10.51 (+1.94%)
Core Lab Announces Reduced Dividend And Expansion Of Cost Reduction Initiatives

Core Laboratories N.V. (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") ("Core", "Core Lab", or the "Company") is announcing immediate actions in response to current market volatility, operational disruption...

CLB : 10.51 (+1.94%)
Core Laboratories (CLB) Down 25.6% Since Last Earnings Report: Can It Rebound?

Core Laboratories (CLB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

CLB : 10.51 (+1.94%)
Core Laboratories (CLB) Matches Q4 Earnings Estimates

Core Laboratories (CLB) delivered earnings and revenue surprises of 0.00% and 1.08%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

CLB : 10.51 (+1.94%)
Core Laboratories: 4Q Earnings Snapshot

AMSTERDAM (AP) _ Core Laboratories NV (CLB) on Wednesday reported fourth-quarter earnings of $10.3 million.

CLB : 10.51 (+1.94%)
Core Lab Reports Fourth Quarter 2019 Results From Continuing Operations:

Core Laboratories N.V. (NYSE: "CLB US" and Euronext Amsterdam: "CLB NA") ("Core", "Core Lab", or the "Company") reported that continuing operations resulted in fourth quarter 2019 revenue of $156,800,000....

CLB : 10.51 (+1.94%)
CLB Stock Crowded With Sellers

In trading on Monday, shares of Core Laboratories N. .

CLB : 10.51 (+1.94%)
New Strong Sell Stocks for January 16th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today

CDTX : 2.44 (unch)
CAPL : 9.73 (+4.40%)
CLB : 10.51 (+1.94%)
TS : 13.42 (+4.44%)
OCSL : 3.53 (+7.95%)
New Strong Sell Stocks for January 15th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today

SWX : 75.85 (+1.35%)
CLB : 10.51 (+1.94%)
LB : 13.92 (+10.92%)
DLA : 9.70 (+2.11%)
NTR : 35.85 (+4.22%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Trade CLB with:

Business Summary

Core Laboratories N.V. is a leading provider of proprietary and patented Reservoir Description and Production Enhancement services. Core Laboratories' reservoir optimization technologies are used to increase total recovery from existing fields. Core Laboratories' services enable clients to optimize reservoir...

See More

Key Turning Points

2nd Resistance Point 10.92
1st Resistance Point 10.62
Last Price 10.51
1st Support Level 9.81
2nd Support Level 9.30

See More

52-Week High 75.63
Fibonacci 61.8% 49.29
Fibonacci 50% 41.15
Fibonacci 38.2% 33.02
Last Price 10.51
52-Week Low 6.68

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar